secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2026-06-02T10:02:26+00:00
Accession:  0001773751-26-000091
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers completes acquisition of Eucalyptus; reaffirms 2030 targets of $6.5B revenue
--------------------------------------------------------------------------------

- Acquisition closed, making Hims & Hers the world's largest consumer health platform.
- Eucalyptus brings 850K+ customers and presence in Australia, Canada, Germany, Japan, UK.
- Company reaffirms long-term targets: $6.5B revenue and $1.3B Adjusted EBITDA by 2030.
- Tim Doyle, former Eucalyptus CEO, appointed SVP International at Hims & Hers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375126000091/0001773751-26-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375126000091/hims-20260529.htm
  HTML page:      https://secwatch.observer/filing/0001773751-26-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer